Literature DB >> 9184597

Community-based study of Lennox-Gastaut syndrome.

H Heiskala1.   

Abstract

PURPOSE: Before 1986, the spectrum of childhood epilepsies, including Lennox-Gastaut syndrome (LGS) and Doose syndrome (DS), known collectively as "epilepsia myoclonica astatica," was believed to represent a single disease. More recently, some investigators have considered these syndromes to be parts of a continuum. To clarify these theories, neurobiologic factors of the syndromes were studied to determine which qualities were shared and which were unique.
METHODS: A retrospective (1975-1985), community-based (Helsinki metropolitan area and the province of Uusimaa) study was designed to seek children with features of LGS and DS. It was assumed that recall bias and the selection of documented history would be similar throughout the group. Ranks of increasing pathology were assigned to different seizure types, EEG results, and drug treatments. A similar procedure was applied to epidemiologic data. Spearman rank-order correlations were calculated to determine which features correlated with LGS and which correlated with less severe epilepsy.
RESULTS: The survey comprised 75 patients with broadly defined LGS. The annual incidence was 2 in 100,000 children aged 0 to 14 years. Prenatal or perinatal abnormalities did not correlate with severity of epilepsy. As compared with the relatively favorable ranks, the severe epilepsy ranks were more often associated with an early onset of epilepsy, an infectious disease at the onset, delayed development before epilepsy, abnormalities in neurologic or neuroradiologic examinations, and a deteriorating course of the condition.
CONCLUSIONS: Patients with LGS are more likely than patients with less severe epilepsy to have a younger age at onset of epilepsy, an infection or both, and a deteriorating course of the condition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184597     DOI: 10.1111/j.1528-1157.1997.tb01136.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

Review 2.  Epilepsy in Muenke syndrome: FGFR3-related craniosynostosis.

Authors:  Nneamaka B Agochukwu; Benjamin D Solomon; Andrea L Gropman; Maximilian Muenke
Journal:  Pediatr Neurol       Date:  2012-11       Impact factor: 3.372

Review 3.  Lennox-Gastaut syndrome: a comprehensive review.

Authors:  Ali A Asadi-Pooya
Journal:  Neurol Sci       Date:  2017-11-09       Impact factor: 3.307

4.  Resting-state activity in development and maintenance of normal brain function.

Authors:  Carolyn E Pizoli; Manish N Shah; Abraham Z Snyder; Joshua S Shimony; David D Limbrick; Marcus E Raichle; Bradley L Schlaggar; Matthew D Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

5.  Association of GABAA Receptor Gene with Epilepsy Syndromes.

Authors:  Musadiq Ahmad Bhat; Sameer Ahmad Guru; Rashid Mir; Ajaz Ahmad Waza; Mariyam Zuberi; Mamta Pervin Sumi; Shaam Bodeliwala; Vinod Puri; Alpana Saxena
Journal:  J Mol Neurosci       Date:  2018-05-21       Impact factor: 3.444

Review 6.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

7.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

8.  The role of epilepsy surgery in the treatment of childhood epileptic encephalopathy.

Authors:  Husam R Kayyali; Ahmed Abdelmoity; Saleh Baeesa
Journal:  Epilepsy Res Treat       Date:  2013-04-18

9.  Epileptic encephalopathies: an overview.

Authors:  Sonia Khan; Raidah Al Baradie
Journal:  Epilepsy Res Treat       Date:  2012-11-20

10.  Lennox gastaut syndrome, review of the literature and a case report.

Authors:  Tareq Abu Saleh; Lawrence Stephen
Journal:  Head Face Med       Date:  2008-06-09       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.